Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Daiichi Sankyo
Baxter
Novartis
Citi
Accenture
Chubb
Express Scripts
Boehringer Ingelheim
Julphar
Cerilliant

Generated: August 17, 2017

DrugPatentWatch Database Preview

Purepac Pharm Company Profile

« Back to Dashboard

What is the competitive landscape for PUREPAC PHARM, and what generic and branded alternatives to PUREPAC PHARM drugs are available?

PUREPAC PHARM has one hundred and thirty approved drugs.

There are two tentative approvals on PUREPAC PHARM drugs.

Summary for Applicant: Purepac Pharm

Patents:0
Tradenames:62
Ingredients:61
NDAs:130
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Purepac Pharm
METHYLTESTOSTERONE
methyltestosterone
TABLET;BUCCAL, SUBLINGUAL080475-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Purepac Pharm
METHYLDOPA AND HYDROCHLOROTHIAZIDE
hydrochlorothiazide; methyldopa
TABLET;ORAL070688-001Apr 24, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe
Purepac Pharm
AMPICILLIN TRIHYDRATE
ampicillin/ampicillin trihydrate
FOR SUSPENSION;ORAL061980-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Purepac Pharm
MEPROBAMATE
meprobamate
TABLET;ORAL084804-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Purepac Pharm
AMPICILLIN TRIHYDRATE
ampicillin/ampicillin trihydrate
FOR SUSPENSION;ORAL061980-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

AstraZeneca
Healthtrust
Moodys
Mallinckrodt
Chubb
Accenture
Cantor Fitzgerald
Cerilliant
Daiichi Sankyo
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot